FDA Inspection 619163 — Aarti Pharmalabs Limited (Custom Synthesis Division)
The FDA completed an inspection of Aarti Pharmalabs Limited (Custom Synthesis Division) on Oct 1, 2009 in Vapi, Valsad. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Oct 1, 2009
- Fiscal Year
- 2010
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Vapi, Valsad (India)